Integrated DNA Technologies (IDT), the global leader in nucleic acid synthesis, announces its 2016 Platinum Level sponsorship of the International Genetically Engineered Machine (iGEM) competition.
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....
Universities, funders and publishers of research do not adequately value the contributions of individuals who participate in “team science”, particularly those at the early stages of their research careers, according to a new report from the Academy of Medical Sciences.
As Team Science becomes more common, this lack of credit, if not addressed, could lead talented people to drop out of science, abandon research or avoid participating in large collaborative projects. Team science, or collaborative and multidisciplinary research, is increasingly at the heart of biomedical discoveries and breakthroughs. It is essential to tackle global issues which require the contribution of different disciplines and...
TxCell SA , a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T-cells to treat severe chronic inflammatory and autoimmune diseases, announces today the launch of its new process industrialization laboratories and technology transfer academy facilities in Sophia Antipolis, France.
These new facilities will be primarily dedicated to the improvement of the existing TxCell manufacturing process for its ASTrIA platform as well as to the development of a manufacturing process for its new ENTrIA platform. These developments will be primarily achieved by combining the integration into the manufacturing process of findings from TxCell research with industry advancements in the life science and technology.
Until 30th June 2016 researchers and technicians can enjoy savings of up to 25% off selected products with the Eppendorf Advantage™ Spring offers.
During the promotional period, a wide range of Eppendorf’s high quality, affordable solutions, including the Eppendorf Xplorer®, epMotion®, Mastercycler® nexus gradient, HeatSealer S100, and MiniSpin® plus are being offered at a special reduced rate. Designed to deliver improved efficiency and productivity in the laboratory, Eppendorf’s solutions reach new levels of simplicity allowing work to be carried out easier and faster...
Life Science’s Minister George Freeman MP visited Charnwood Campus in Loughborough to meet the team responsible for the transformation of the world-class pharmaceutical site, and to discuss its potential role in strengthening the local economy.
His visit coincided with the publication of a new report, ‘Transforming Life Sciences Sites – a toolkit for action’ by a group of senior stakeholders from across the UK¹. During his tour, the Minister was briefed on how the anchor tenant, Almac Group, is upgrading the facilities to provide office and laboratory space, analytical testing, formulation development, and small and large scale manufacturing facilities. Senior Almac representatives presented...
We bring you more exciting news about Photonex London Roadshow.
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Bedfont Scientific Ltd. has sold its U.K. subsidiary, NOxBOX Ltd, to Praxair Gases UK, Ltd., a subsidiary of Praxair, a Fortune 250 company with 2015 sales of $11 billion and one of the largest industrial gas companies worldwide.
Financial terms of the transaction were not disclosed. Bedfont’s sale of NOxBOX Ltd includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy. This announcement comes shortly after Bedfont announced the move to create the subsidiary NOxBOX Ltd after unprecedented success with the NOxBOX® range of products, which have been globally available in different forms since 1997...
World renowned standards company, Whitehouse Scientific, will exhibit its unique range of filter calibration products and services on Booth A1212 at the 12th World Filtration Congress (Taipei International Convention Center, Taiwan: 11-15th April 2016).
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...
OHAUS manufactures an extensive line of high-precision electronic and mechanical balances and scales that meet the demands of virtually any weighing need. The company is a global leader in the laboratory, industrial, and education channels as well as a host of specialty markets, including the food preparation, pharmacy and jewelry industries. OHAUS products are precise, reliable and affordable, and are backed by industry-leading customer support.
Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou™s intellectual property.
The license is subject to a research use limited label. "We are proud to partner with Integrated DNA Technologies, a prominent leader in the field of nucleic acid based technologies",
PAREXEL International Corporation a leading global biopharmaceutical services organisation, today announced expanded services and capabilities in genomic-based drug development.
The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes. Biopharmaceutical companies are increasingly applying genomics to drug discovery and development to better understand the genetic basis of disease, drug targets, and drug response. Over the next five years...
Haydale, a leader in the development of enhanced graphene and nanoparticulate materials, has announced that it has been awarded a number of research grants, totalling £350k, which will help accelerate the development of new products enhanced by the incorporation of functionalised graphene and other nanomaterials.
These new projects include:The development of electrically conductive graphene enhanced adhesives for aircraft structures. The ability to conduct electricity from lightning strikes throughout a composite aircraft fuselage, including bonded joints, is essential for improved safety. This work builds on an existing research project to develop electrically conductive carbon fibre composite materials for aircraft construction...
Dean Street Express Expanding to Additional Locations using GeneXpert Infinity System
Cepheid have announced the delivery of the 10,000th GeneXpert® System to the 10 Hammersmith Broadway Clinic in London, England. The Hammersmith Clinic is the first in a series of new clinics developed by the same team behind the innovative Dean Street Express clinic located in London’s Soho district that has been transforming the model for STD testing and public health since it first opened in February 2014. Dean Street Express.....
Read MoreSartorius Named Fisher Scientific European Supplier of the YearMar 24, 2016
Thermo Fisher Scientific, the world leader in serving science, recently announced the winners of the Fisher Scientific Supplier Awards during its fifth Fisher Scientific European Sales Conference in Malta.
From January 26-28, 2016, more than 700 delegates attended the Fisher Scientific European Sales Conference at the InterContinental, Malta. This was the fifth event of its kind, bringing together delegates from 18 different countries. The three-day event included an exhibition showcase with 68 booths featuring laboratory products from Thermo Fisher Scientific and other leading suppliers. The event culminated in a...
Metrohm USA is proud to announce that Regulatory Affairs Manager, Dr. Jay Gandhi has been awarded the Award of Merit from the ASTM.
Established in 1949 by the ASTM International Board of Directors, the Award of Merit is the highest society award granted to an individual member for distinguished service and outstanding participation in ASTM International committee activities. The Award of Merit was presented to Jay in recognition of his outstanding contributions to Committee D19 on Water through standardization of test methods and the management of inter-laboratory studies related to...
Ubiquigent Limited, a company specialising in providing ubiquitin cell-signalling system drug discovery services and research tools, announced today that it has significantly enhanced its drug discovery service capabilities by strengthening its commercial and chemistry teams to deliver an even more comprehensive range of services to the global life science research community.
Jason Mundin has joined the board as Commercial Director to drive the growth of Ubiquigent along with Jason Brown, founder and now Scientific Director and Mark Treherne, Executive Chairman. Laurence Ede also joins as a non-executive director to support the development of the company. John Harris has joined the Scientific Advisory Board to lead Ubiquigent’s new chemistry strategy. Ubiquigent also announced the...
Today the world's no. 2 influenza vaccine provider, Seqirus, announced a £22.1m investment for its UK manufacturing site in Liverpool.
The company, which is part of global biotherapeutics leader CSL Limited, is going to develop a new £15.3m manufacturing facility to support the production of influenza vaccines at its Speke site. The announcement came as Seqirus today celebrated the opening of a £6.8m investment in new warehousing facilities at the site. Seqirus was created in November 2015 following CSL's acquisition of the Novartis influenza vaccines...
A University of Brighton professor has become the first British citizen to join one of America?s leading organisations supporting research into ageing.
Professor Richard Faragher, Professor of Biogerontology and assistant head of the School of Pharmacy and Biomolecular Sciences, has been elected to the board of directors of the American Federation for Aging Research (AFAR). AFAR is a national non-profit organization whose mission is to support and advance healthy ageing through biomedical research. Founded in 1981, AFAR has championed the cause and supported the funding of science in healthier ageing and...
Micreos intends to use the secured funds, which run until 2017, for the global development of Staphefekt™ as a pharmaceutical (Rx) product. Micreos develops targeted antibacterial technology as a sustainable alternative to antibiotics for which it is a recognised leader in the field. Gladskin is the world’s first lysin (enzyme) based product registered for human use. It specifically targets S. aureus, including MRSA on intact skin...
Sophia Genetics announces a strategic partnership with Integrated DNA Technologies to accelerate the adoption of next generation sequencing (NGS) in routine clinical diagnostics.
The Sophia DDM™ advanced analytical platform will be paired with IDT’s xGen® hybridization-based target enrichment panels to provide hospitals with excellent analytical performance, unrivalled flexibility for gene panel composition, and high sample throughput. The NGS bundles will be available immediately to more than 120 hospitals currently using the Sophia DDM™ platform. As additional hospitals add this platform to...
Read MoreGenome Editing: a Scientific RevolutionMar 16, 2016
A distinguished panel of experts from four leading bioscience research institutes come together during this year’s Cambridge Science Festival to discuss and respond to public questions about the current and future applications of genome editing – a process by which sections of DNA are removed or replaced.
Human genomes contain natural errors or mutations. Most are relatively harmless and underpin evolution but some cause life-threatening diseases. In a few cases, patients have been treated by conventional gene therapy, where new genes are incorporated using a carrier virus to counteract defective genes. However, so far few patients have been treated by genomic editing. This could all change now that new and much...
The iGEM Foundation conducts a yearly international competition for students interested in synthetic biology. Last year, more than 280 teams from 39 countries participated in the competition. IDT also will provide each registered team with up to 20KB of its market leading gBlocks® Gene Fragments synthetic DNA products—for a total value of almost US$1M. “We are very proud to continue our support of iGEM teams that enable...
“2015 was not only an eventful, but above all a very successful year for Merck. We again achieved profitable growth. By acquiring Sigma-Aldrich, we successfully completed the portfolio realignment of recent years. In immuno-oncology, we initiated six pivotal clinical trials. Research advances and future-oriented investments form the foundation for future success. And our new bold and vibrant branding shows what makes Merck unique,” said Karl-Ludwig Kley, Chairman of the Executive Board....
As Team Science becomes more common, this lack of credit, if not addressed, could lead talented people to drop out of science, abandon research or avoid participating in large collaborative projects. Team science, or collaborative and multidisciplinary research, is increasingly at the heart of biomedical discoveries and breakthroughs. It is essential to tackle global issues which require the contribution of different disciplines and...
These new facilities will be primarily dedicated to the improvement of the existing TxCell manufacturing process for its ASTrIA platform as well as to the development of a manufacturing process for its new ENTrIA platform. These developments will be primarily achieved by combining the integration into the manufacturing process of findings from TxCell research with industry advancements in the life science and technology.
During the promotional period, a wide range of Eppendorf’s high quality, affordable solutions, including the Eppendorf Xplorer®, epMotion®, Mastercycler® nexus gradient, HeatSealer S100, and MiniSpin® plus are being offered at a special reduced rate. Designed to deliver improved efficiency and productivity in the laboratory, Eppendorf’s solutions reach new levels of simplicity allowing work to be carried out easier and faster...
His visit coincided with the publication of a new report, ‘Transforming Life Sciences Sites – a toolkit for action’ by a group of senior stakeholders from across the UK¹. During his tour, the Minister was briefed on how the anchor tenant, Almac Group, is upgrading the facilities to provide office and laboratory space, analytical testing, formulation development, and small and large scale manufacturing facilities. Senior Almac representatives presented...
The programme has now been finalised with an excellent calibre of speakers set to give presentations. Attend this event to broaden your knowledge in the world of photonics by attending a key meeting for photonics technologies in the life sciences. The technical committee have commented that this international quality 'invited' programme includes presentations by eminent and leading European research scientists...
Financial terms of the transaction were not disclosed. Bedfont’s sale of NOxBOX Ltd includes the full NOxBOX range of critical care delivery and monitoring devices for inhaled nitric oxide therapy. This announcement comes shortly after Bedfont announced the move to create the subsidiary NOxBOX Ltd after unprecedented success with the NOxBOX® range of products, which have been globally available in different forms since 1997...
Dr Graham Rideal, CEO of Whitehouse Scientific, will also present a paper on the latest developments in wet challenge testing to accurately define pore size in a filter, to an audience of scientists, engineers and practitioners operating in the filtration field. Dr Rideal™s presentation, Latest Developments in Wet Challenge Testing, will highlight the importance of being able to accurately measure maximum pore size in filters across a wide...
OHAUS manufactures an extensive line of high-precision electronic and mechanical balances and scales that meet the demands of virtually any weighing need. The company is a global leader in the laboratory, industrial, and education channels as well as a host of specialty markets, including the food preparation, pharmacy and jewelry industries. OHAUS products are precise, reliable and affordable, and are backed by industry-leading customer support.
The license is subject to a research use limited label. "We are proud to partner with Integrated DNA Technologies, a prominent leader in the field of nucleic acid based technologies",
The PAREXEL® Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer approval processes. Biopharmaceutical companies are increasingly applying genomics to drug discovery and development to better understand the genetic basis of disease, drug targets, and drug response. Over the next five years...
These new projects include: The development of electrically conductive graphene enhanced adhesives for aircraft structures. The ability to conduct electricity from lightning strikes throughout a composite aircraft fuselage, including bonded joints, is essential for improved safety. This work builds on an existing research project to develop electrically conductive carbon fibre composite materials for aircraft construction...
From January 26-28, 2016, more than 700 delegates attended the Fisher Scientific European Sales Conference at the InterContinental, Malta. This was the fifth event of its kind, bringing together delegates from 18 different countries. The three-day event included an exhibition showcase with 68 booths featuring laboratory products from Thermo Fisher Scientific and other leading suppliers. The event culminated in a...
Established in 1949 by the ASTM International Board of Directors, the Award of Merit is the highest society award granted to an individual member for distinguished service and outstanding participation in ASTM International committee activities. The Award of Merit was presented to Jay in recognition of his outstanding contributions to Committee D19 on Water through standardization of test methods and the management of inter-laboratory studies related to...
Jason Mundin has joined the board as Commercial Director to drive the growth of Ubiquigent along with Jason Brown, founder and now Scientific Director and Mark Treherne, Executive Chairman. Laurence Ede also joins as a non-executive director to support the development of the company. John Harris has joined the Scientific Advisory Board to lead Ubiquigent’s new chemistry strategy. Ubiquigent also announced the...
The company, which is part of global biotherapeutics leader CSL Limited, is going to develop a new £15.3m manufacturing facility to support the production of influenza vaccines at its Speke site. The announcement came as Seqirus today celebrated the opening of a £6.8m investment in new warehousing facilities at the site. Seqirus was created in November 2015 following CSL's acquisition of the Novartis influenza vaccines...
Professor Richard Faragher, Professor of Biogerontology and assistant head of the School of Pharmacy and Biomolecular Sciences, has been elected to the board of directors of the American Federation for Aging Research (AFAR). 
Micreos intends to use the secured funds, which run until 2017, for the global development of Staphefekt™ as a pharmaceutical (Rx) product. Micreos develops targeted antibacterial technology as a sustainable alternative to antibiotics for which it is a recognised leader in the field. Gladskin is the world’s first lysin (enzyme) based product registered for human use. It specifically targets S. aureus, including MRSA on intact skin...
The Sophia DDM™ advanced analytical platform will be paired with IDT’s xGen® hybridization-based target enrichment panels to provide hospitals with excellent analytical performance, unrivalled flexibility for gene panel composition, and high sample throughput. The NGS bundles will be available immediately to more than 120 hospitals currently using the Sophia DDM™ platform. As additional hospitals add this platform to...
Human genomes contain natural errors or mutations. Most are relatively harmless and underpin evolution but some cause life-threatening diseases. In a few cases, patients have been treated by conventional gene therapy, where new genes are incorporated using a carrier virus to counteract defective genes. However, so far few patients have been treated by genomic editing. This could all change now that new and much...